9-CHLORO-11.BETA.-HYDROXY-2',2'-DIMETHYL-3,20-DIOXO-(16.BETA.H)-(1,3)DIOXOLO(4',5':16,17)PREGNA-1,4-DIEN-21-YL 3,3-DIMETHYLBUTANOATE
UNII 3KRX2V3ZGQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-chloro-11.beta.-hydroxy-2',2'-dimethyl-3,20-dioxo-(16.beta.h)-(1,3)dioxolo(4',5':16,17)pregna-1,4-dien-21-yl 3,3-dimethylbutanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3KRX2V3ZGQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H41ClO7 GQWUDLDDLMBIBN-FLRHRWPCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-chloro-11.beta.-hydroxy-2',2'-dimethyl-3,20-dioxo-(16.beta.h)-(1,3)dioxolo(4',5':16,17)pregna-1,4-dien-21-yl 3,3-dimethylbutanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.